The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$37.50

Today's change+2.61 +7.48%
Updated May 27 3:13 PM EDT. Delayed by at least 15 minutes.
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$37.50

Today's change+2.61 +7.48%
Updated May 27 3:13 PM EDT. Delayed by at least 15 minutes.

Valeant Pharmaceuticals International Inc crosses above 20-day moving average

Valeant Pharmaceuticals International Inc is up sharply today, rallying $2.61 or 7.48% to $37.50 and crossing above its 20-day moving average. Over the last five days, shares have gained 4.05%, but are down 73.32% for the last year to date. Shares have underperformed the S&P TSX by 80.67% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward3.71×
  • Forward PEG0.18×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.09
Updated May 27 3:13 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.30%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue2,7362,7872,7322,191
Total other revenue--------
Total revenue2,7362,7872,7322,191
Gross profit2,0602,1392,0471,616
Total cost of revenue677648685575
Total operating expense2,5422,3392,3911,668
Selling / general / administrative743698686574
Research & development961028156
Depreciation / amortization789679585365
Interest expense (income), net operating--------
Unusual expense (income)19518217792
Other operating expenses, total43301776
Operating income195448342523
Interest income (expense), net non-operating-433-420-413-298
Gain (loss) on sale of assets--------
Other--------
Income before tax-240-6-65155
Income after tax-36252-5275
Income tax, total122-57-1381
Net income-36250-5374
Total adjustments to net income--------
Net income before extra. items-36250-5374
Minority interest1-2-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-36250-5374
Inc. avail. to common incl. extra. items-36250-5374
Diluted net income-36250-5374
Dilution adjustment------0
Diluted weighted average shares348351344343
Diluted EPS excluding extraordinary itemsvalue per share-1.040.14-0.150.21
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.540.570.190.34
R